Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
Dextroamphetamine sulfate
(+)-amphetamine
(S)-(+)-amphetamine
(S)-(+)-β-phenylisopropylamine
Dexamphetamine
Dextroamphetamine saccharate
(+)-α-methylphenethylamine
Dexanfetamina
(S)-amphetamine
(S)-1-phenyl-2-aminopropane
(S)-α-methylbenzeneethanamine
Dexamfetaminum
(+)-(S)-amphetamine
Dextroamphetamine adipate
Desamfetamina
Dextroamphetamine
(+)-α-methylphenylethylamine
(αS)-α-methylbenzeneethanamine
Dexamfetamina
Dexamfetamine
d-amphetamine
(S)-1-phenyl-2-propylamine
Brand Names
Mixed Salts of a Single-Entity Amphetamine Product
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER
Zenzedi
Dextroamphetamine
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
